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Abstract
The KCNE1 gene product (minK protein) associates with the cardiac KvLQT1 potassium channel (encoded by KCNQ1) to
create the cardiac slowly activating delayed rectifier, IKs. Mutations throughout both genes are linked to the hereditary
cardiac arrhythmias in the Long QT Syndrome (LQTS). KCNE1 exerts its specific regulation of KCNQ1 activation via
interactions between membrane-spanning segments of the two proteins. Less detailed attention has been focused on the
role of the KCNE1 C-terminus in regulating channel behavior. We analyzed the effects of an LQT5 point mutation (D76N) and
the truncation of the entire C-terminus (D70) on channel regulation, assembly and interaction. Both mutations significantly
shifted voltage dependence of activation in the depolarizing direction and decreased IKs current density. They also
accelerated rates of channel deactivation but notably, did not affect activation kinetics. Truncation of the C-terminus
reduced the apparent affinity of KCNE1 for KCNQ1, resulting in impaired channel formation and presentation of KCNQ1/
KCNE1 complexes to the surface. Complete saturation of KCNQ1 channels with KCNE1-D70 could be achieved by relative
over-expression of the KCNE subunit. Rate-dependent facilitation of K
+ conductance, a key property of IKs that enables
action potential shortening at higher heart rates, was defective for both KCNE1 C-terminal mutations, and may contribute to
the clinical phenotype of arrhythmias triggered by heart rate elevations during exercise in LQTS mutations. These results
support several roles for KCNE1 C-terminus interaction with KCNQ1: regulation of channel assembly, open-state
destabilization, and kinetics of channel deactivation.
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Introduction
The slowly activating delayed rectifier potassium current (IKs)
plays an important role in controlling the repolarizing phase of the
cardiac action potential, particularly during periods of elevated
heart rate. IKs is carried by channels comprised of KCNQ1 pore-
forming subunits and KCNE1 regulatory subunits [1,2]. The
KCNE1 gene product (minK) is a small protein of 129 amino acids
that belongs to the family of K
+ channel-interacting KCNE
proteins, the members of which share structural similarities: a
single membrane-spanning domain, and short C- and N- terminal
tails (intracellular and extracellular, respectively) [3,4]. Though
KCNQ1 expression alone generates a K
+ current, association with
KCNE1 is required for the current to recapitulate cardiac IKs, with
its slow activation and shifted voltage-dependence of activation
[1,2].
In addition to KCNE1, the other four members of the KCNE
family (KCNE2-5, encoding proteins MiRP1-4, respectively) are
capable of associating with KCNQ1 and regulating channel
behavior [5–10]. Since each KCNE affects KCNQ1 channel
gating differently, mutagenesis and chimeras have enabled
investigators to probe which portions of the accessory subunits
provide functional interactions and specificity. By this means, the
structural determinants of KCNE1 and KCNE3 regulation of
KCNQ1 have been investigated to identify the site that controls
activation gating within the KCNE transmembrane domain
(TMD) with single amino acid resolution [11,12]. The KCNQ1
S6 TMD has been analyzed by mutagenesis to identify those
residues that interact with KNCE1 and KCNE3 and which
differentially stabilize open or closed states to account for the
widely differing kinetics of channel activation [13,14].
While many studies have concentrated on the membrane-
spanning region of KCNE1, the role of the cytoplasmic C-
terminus has been less thoroughly explored. Several naturally
occurring Long QT Syndrome (LQTS) mutations have been
found in the C-terminus of KCNE1, as well as in the C-terminal
tail of KCNQ1 that implicate the importance of these regions in
the regulation of IKs [15–18] (http://www.fsm.it/cardmoc/).
Additional mutations in KCNQ1 and other KCNE genes have
been associated with familial atrial fibrillation [19–21]. Congenital
mutations in KCNQ1 and KCNE1 (corresponding to LQTS
subtypes LQT1 and LQT5, respectively), account for over 50% of
inherited LQTS [22], and are associated with arrhythmias
triggered by exercise-related increase in heart rate and b-
adrenergic stimulation [23]. These findings underscore the ability
of IKs to contribute to rate-related adaptation of cardiac
repolarization and maintenance of normal sinus rhythm and
excitability during stress.
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5143In the present study, we focused our investigation on the role of
the KCNE1 C-terminus on regulation and rate-adaptation of IKs.
Our data show that deactivation kinetics—a parameter that has
thus far been given little attention—is significantly affected by
mutations in the C-terminus. We also provide evidence that the C-
terminus truncation or mutation also renders the channel
incapable of adapting IKs current accumulation in response to
increases in pulse rate as does the channel formed by wild-type
KCNE1. Thus, interactions between the KCNE1 C-terminus and
KCNQ1 may play a critical physiological role in rate-related
adaptation of action potential duration, the dysregulation of which
could contribute to LQT1 and LQT5 phenotypes.
Results
To examine the role of the cytoplasmic C-terminus of KCNE1
(amino acid residues 67–129) on KCNQ1/KCNE1 channel
function, we examined two KCNE1 mutants: KCNE1-D76N,
and KCNE1-D70 truncation mutant (Figure 1A). Wild-type
KCNE1 and each mutant were transiently co-transfected with
KCNQ1 in Chinese Hamster Ovary (CHO) cells, and current was
assessed via whole-cell patch clamp. Compared to cells transfected
with KCNQ1 alone, those transfected with KCNQ1 and wild-type
KCNE1 (Figure 1B) exhibited the well-known transformed
KCNQ1 current consistent with IKs. Among the changes caused
by KCNE1 are increase in current density, slowed activation/
deactivation kinetics, shift in voltage dependence of activation
(VDA) and abolishment of inactivation. The KCNE1 C-terminal
mutations D76N and D70 also transformed KCNQ1 currents with
minimal effects on activation rate. Since IKs does not completely
saturate during activating depolarizing steps investigators have
generally chosen to make comparative activation rate measure-
ments in an isochronal fashion [24]. Furthermore, the current
shows a sigmoidal time course of activation indicating multiple
states prior to a conducting one, so for simplicity, the time to half
maximal conductance has been accepted as a measure of relative
activation rate [11,13,14,25]. Figure 2A shows the summary data
for activation rates, analyzed as the time required to reach half-
maximal conductance. The current density in cells expressing
channels comprised of KCNQ1/KCNE1-D76N were reduced
compared to wild type KCNE1 (Figure 2B) and have been
attributed to changes in open probability (Po) and unitary
conductance [26,27]. The KCNE1-D70 mutant yielded a similar
current density reduction as that of the D76N. To determine if the
KCNE1 mutants affected current density by altering the amount
of KCNQ1 channel protein we examined immunoblots from cells
expressing the various combinations of channel subunits
(Figure 2C). Neither wild type KCNE1 nor its mutants changed
the abundance of KCNQ1 protein. Immunoblots in Figure 2C
show that comparable amounts of the different KCNE1 proteins
are expressed but do not specifically address surface expression.
That the current is transformed by both the KCNE1-D76N and
KCNE1-D70 is solid evidence for surface localization and
association with KCNQ1. A recent report suggests that
KCNE1-D76N is shunted away from the plasma membrane by
endocytosis without trafficking back via recycling endosomes when
cells are stimulated with SGK1 [28]. Such a mechanism may play
a role in the generally observed reduction of current density with
the mutant subunit but in our studies there was no additional
SGK1 stimulation which may explain the comparably abundant
mutant and wild type protein.
The C-terminal KCNE1 mutations also caused a more
pronounced rightward shift of the voltage-dependence of activa-
tion (VDA) when compared to wild type KCNE1 (Figure 3). The
Vh values, as estimated by Boltzmann curve fits of VDA data, are
listed in Table 1 (p,0.001 for both mutants compared to wild-type
KCNE1). That the C-terminal mutants shifted the VDA suggests
that the C-terminus contributes to activation gating mechanism by
stabilizing the closed state or destabilizing the open state without
affecting the kinetics of activation.
Figure 4A illustrates the involvement of KCNE C-terminus in
the kinetics of deactivation. Co-expression of KCNQ1 and
Figure 1. A) Schematic of KCNQ1 subunit and KCNE1, showing location of KCNE1 mutations. B) Current traces of activation protocol, with protocol in
inset.
doi:10.1371/journal.pone.0005143.g001
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PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5143Figure 2. KCNE1 mutations D76N and D70 reduce IKs current density with minimal effects on activation kinetics. A) rates of activation,
and B) current density from CHO cells transiently expressing Myc-tagged KCNQ1 (Q1) either without KCNE1 (E1), or with wild-type FLAG-tagged E1,
E1-D76N, or E1-D70. Asterisks (*) indicate statistical significance to P,0.001. n=6. C) Immunoblot showing KCNQ1 protein levels when expressed
alone or co-expressed with KCNE1 (wild-type and mutant). Western blot analysis performed with mouse anti-Myc antibody (Santa Cruz) for KCNQ1,
and mouse anti-FLAG antibody (Sigma) for KCNE1. Left lane in each gel shows signal from cells that are untransfected.
doi:10.1371/journal.pone.0005143.g002
Figure 3. KCNE1-D76N and KCNE1-D70 shift the voltage dependence of activation of IKs. A) voltage-dependent activation curves, and B)
normalized activation curves. Curves were fitted using a Boltzmann function. Vh for KCNQ1=230.361.0 mV, KCNQ1/KCNE1=9.564.2 mV, KCNQ1/
KCNE1-D76N=43.563.0 mV, KCNQ1/KCNE1-D70=71.567.0 mV. n=6, p,0.001 for both mutants compared to wild-type KCNE1.
doi:10.1371/journal.pone.0005143.g003
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removal of the inactivation ‘‘hook’’ on the tail current. Both
KCNE1 mutations significantly accelerate deactivation at all
voltages compared to wild type KCNE1. The mutants also
accelerated deactivation compared to KCNQ1 alone at voltages
positive to 280 mV (Figure 4B). These results suggest that the C-
terminus of KCNE1 interacts with the channel to determine
voltage-dependent deactivation. This regulation may occur
through interactions between the KCNE1 terminus and intracel-
lular portions of KCNQ1. Mutations in the KCNE1 C-terminus
may thus affect the normal interaction between the proteins via
disruption or the formation of new interactions that are
consequential to deactivation rates. Though the deactivation
profile of the KCNE1-D76N mutant resembles that of the
KCNE1-D70 mutant, the D76N mutation did not abolish the
interaction between the KCNQ1 and KCNE1 C-termini. Co-
expression of KCNE1 C-terminal fragments (lacking the N-
terminus and the transmembrane domain) with full-length
KCNQ1 resulted in quantifiable binding (detected by co-
immunoprecipitation) that was not prohibited by the KCNE1-
D76N mutation nor other D76 mutations (D76E or D76A)
(Figure 4C). Thus, any functional change caused by this mutation
is not due to elimination of interaction between KCNQ1 and the
C-terminus of KCNE1, but rather by more subtle changes in
interaction that result in a change in channel gating.
We also investigated the physical association of KCNE1 C-
terminal mutants with KCNQ1 channels by co-immunoprecipi-
tation (co-IP) experiments. As shown in Figure 5A, KCNE1-D76N
and KCNE1-D70 achieve expression levels as high as or higher
than wild type KCNE1 in CHO cells co-transfected with
KCNQ1. When KCNQ1 was immunoprecipitated, wild type
and D76N KCNE1 co-precipitated to a comparable extent. The
Table 1. Biophysical characteristics of KCNE1 mutants.
Current Density Activation Time K Max Vh DG(CRO) DEa(ORC)
Units pA/pF msec mV kJ/mol kJ/mol
KCNQ1 35.2268.00 22.2861.40 230.361.01 ND ND
KCNQ1+KCNE1 410.92638.39 1150.656136.66 9.5364.16 1.58 ND
KCNQ1+KCNE1-D76N 102.95620.41 1338.88659.42 43.4662.97 5.75 22.5060.32
KCNQ1+KCNE1-D70 63.95616.97 1209.37662.63 71.7467.04 9.8 23.1460.38
N=6.
Abbreviations: Vh voltage at which half the channels are activated; DG(CRO) change in Gibbs free energy for the closed and open states during channel activation;
DEa(ORC) change in activation energy for the transition from open to closed states relative to wild-type KCNE1. (ND, not done).
doi:10.1371/journal.pone.0005143.t001
Figure 4. Deactivation rates are accelerated by both KCNE1-D76N and KCNE1-D70. A) Current traces, with deactivation protocol in inset,
and B) rates of deactivation plotted against voltage from CHO cells transiently expressing KCNQ1 (Q1) either without KCNE1 (E1), or with wild-type E1,
E1-D76N, or E1-D70. Asterisks (*) indicate significant change between wild-type E1 and both E1 mutations. n=6. C) Co-immunoprecitation
experiment of C-termini KCNE1 with full length KCNQ1. Full length KCNQ1 was expressed with KCNE1 C-terminus (KCNE1-CT), either wild-type or with
D76E, D76N, or D76A point mutations. Immunoprecipitation was performed with goat anti-KCNQ1 antibody, and immunoblot with rabbit anti-FLAG
antibody (Santa Cruz). For controls, lane 1 shows results from untransfected cells, lane 2 from KCNQ1 alone, lane 3 from KCNE1 wild type (D76) alone,
and lane 4 from KCNQ1 and KCNE1 with control antibody. The different KCNE1 forms are designated by the single amino acid letter at the 76
th
position.
doi:10.1371/journal.pone.0005143.g004
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suggesting that the truncated mutant had an intrinsically lower
affinity for the channel, while the wild type and D76N mutant had
similar affinity or association. At this point however, we cannot
exclude the possibility that the KCNE1-D70 binds to another
cellular protein with higher affinity than KCNQ1, thereby
preventing it from participating in channel formation. The lower
apparent affinity of the D70 mutant was also functionally manifest
as current with activation kinetics different than either KCNQ1
alone or KCNQ1/KCNE1 when cells were transfected with
equimolar amounts of KCNQ1 and KCNE1-D70 (Figure 5B).
These hybrid currents had initial fast activation characteristic of
KCNQ1, followed by slow continued activation characteristic of
IKs. When a pure KCNQ1 current was scaled to the amplitude of
the initial rapid activation phase of the hybrid current and digitally
subtracted, the resulting signal recapitulated IKs activation kinetics
of KCNQ1/KCNE1. To ensure that the KCNE1-D70 protein did
not generate any unpredicted conductances that might contam-
inate the KCNQ1/KCNE1 channel currents, we examined cells
transfected with the KCNE1-D70 alone and observed no currents
(Figure 5C). Thus, the hybrid current represented an algebraic
sum of two populations of channels—KCNQ1 alone plus
KCNQ1/KCNE1-D70. To achieve saturation of KCNQ1 with
KCNE1-D70 subunits we transfected cells with higher KCNE1 to
KCNQ1 cDNA ratios. Cells showing mixed currents due to non-
stoichiometric association were not included in the kinetic
analyses. In this way we were able to distinguish between
association/assembly functions of the KCNE1-C-terminus and
the purely biophysical functions. That KCNE1-D70 truncation
results in lower amounts co-immunoprecipitated by KCNQ1,
suggests a possible role for the KCNE1 C-terminus that favors
association or assembly of the channel complex but is not
absolutely required.
The physiological effects of C-terminal mutations were
examined by assessing rate-related current accumulation. In
normal cardiac physiology, action potential durations (APD)
shorten in response to elevated heart rate, which is a necessary
accommodation in order to maintain a proper ratio of time spent
in electrical systole to time spent in diastole [29–33]. The inability
to accommodate action potential duration results in early after-
depolarizations, which can trigger tachyarrhythmias. The activity
of delayed rectifier currents (IKr and IKs) may contribute to the
shortening of APDs through cycle-length-related accumulation of
open channels [34–37]. In our whole-cell patch clamp recordings
where we simulated trains of action potentials at different
frequencies mimicking normal and elevated heart rates, wild-type
KCNQ1/KCNE1 channels exhibited marked accumulation of K
+
conductance at the frequencies between 120 and 150 depolariza-
Figure 5. A) Co-immunoprecipitation of wild-type and mutant KCNE1 with KCNQ1. KCNQ1 (Q1) was expressed with KCNE1 (E1), E1-D76N, or E1-D70.
KCNQ1 was immunoprecipitated with goat anti-KCNQ1 antibody (Santa Cruz), and western blot analysis performed with mouse anti-FLAG antibody
(Sigma). The asterisks (*) indicate a row of nonspecific bands that appeared in every lane, including control lanes. For controls, lane 1 shows results
from untransfected cells, lanes 2–4 from cells transfected with KCNQ1 and KCNE1 (WT, D76N, or D70 as indicated) and pulled down with control IgG.
B) Digital subtraction of Q1 current from mixed Q1-E1 current (E1-D70 mutant). Left tracing shows the currents obtained from a cell transfected with a
1:1 ratio of KCNQ1:KCNE1-D70 plasmids. Middle tracing shows a pure KCNQ1 current scaled to match the amplitude of the initial rapid current
deflection seen in the mixed current to the left. Right side tracing shows the resulting digital subtraction of the two currents resulting in a current
with slow sigmoidal activation characteristic of IKs. C) Voltage clamp tracing from cells transfected with KCNE1-D70 plasmid alone demonstrating that
the mutant KCNE1 did not induce any other conductances on its own.
doi:10.1371/journal.pone.0005143.g005
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depolarization was shortened proportionally to cycle length (i.e.
shortened APD for faster rates), accumulation did not occur
(Figure 6B). Neither KCNQ1/KCNE1-D76N nor KCNQ1/
KCNE1-D70 exhibited accumulation of current (Figures 6C and
6D). This defective current accumulation at shorter cycle lengths
may contribute to triggering arrhythmias in patients with LQTS
mutations that affect C-terminal interactions between KCNQ1
and KCNE1.
Discussion
The results presented here provide evidence that the KCNE1 C-
terminus plays an important role in the regulation of KCNE1
channels, and in IKs adaptation to changes in heart rate. The C-
terminus of KCNE1 is necessary to transform the fast deactivation
kinetics of KCNQ1 current to the slow deactivation kinetics of IKs.
Furthermore, the deactivation kinetics of IKs are sensitive to an
LQT-linked single amino acid mutation in the C-terminus of
KCNE1. The presence or absence of the C-terminus of KCNE1
plays a roleinthe affinity orlikelihood of association of KCNE1 with
KCNQ1. The KCNE1-D76N mutation however, did not exert its
effect via disruption of association. The acceleration of channel
deactivation by KCNE1 C-terminal point mutation or truncation
also renders the channel incapable of adapting to increases in heart
rate, which may contribute to some LQT5 phenotypes.
Previous studies have identified the precise site in the
transmembrane domain of KCNE1 that controls IKs activation
kinetics [11,12]. These studies, however, also showed that
deactivation kinetics are not controlled by the same region [11].
Evidence from several groups suggests the importance of the C-
terminus as a region critical for normal KCNE1 function. Early
on, Takumi et al. showed that mutations in the C-terminal region
of KCNE1 were poorly tolerated, resulting in a reduction in
channel activity [38]. The effects of several of these mutations,
including D76N, were confirmed by Sesti et al., who showed that
the mutant channels had lower unitary currents and diminished
open probabilities, but only minor changes in ionic permeability
[27].
Our present data confirms that control of IKs activation rate lies
outside of the C-terminus: the KCNE1-D70 truncation mutation
did not alter the activation profile of IKs when coupled to
KCNQ1. Neither KCNE1-D76N or -D70 produced a channel
with KCNQ1 that yielded constitutively activated conductance as
has been seen with KCNE3 [11,12,39]. The voltage dependence
of activation, however, was significantly right-shifted by ,60 mV.
A shift in VDA indicates a change in the relative free energy (DG)
of the closed and open states of the channel, versus a change in the
activation energy (or transition-state energy barrier, DEa), which
would be reflected by altered activation kinetics. The other
prominent effect of the KCNE1-D70 mutation was the significant
acceleration of deactivation kinetics of the KCNQ1/KCNE1
channel.
Similar results characterize the functional effects of the D76N
mutant. The increase in the DG of opening of both mutants
compared to wild-type causes a rightward shift in the VDA curve
Figure 6. KCNE1-D76N and KCNE1-D70 mutations result in defective rate-related accumulation of IKs current. A series of 100 pulses
mimicked action potential trains at three rates: 60, 120, or 150 per minute. On the voltage protocol, the grey stripe indicates the 10 ms over which
the current measured was averaged and plotted on the graphs. The insets for B, C, and D show the Y-axis magnified and the points plotted without
error bars. X- and Y-axes labels are the same as the main graph. A) Cells transfected with KCNQ1 (Q1) and wild-type KCNE1 (E1); depolarization length
325 ms. B) Cells transfected as in A, but depolarization length of voltage protocol adjusted as follows: 60 pulses/min-325 ms; 120 pulses/min-175 ms;
150 pulses/min-145 ms. C) Cells transfected with Q1 and E1-D76N; depolarization length 325 ms. D) Cells transfected with Q1 and E1-D70;
depolarization length 325 ms. n=6.
doi:10.1371/journal.pone.0005143.g006
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destabilization of the open state. There was little difference in
activation energy for channel opening with the KCNE1 mutants
since the kinetics for channel activation were largely unchanged
(Table 1). There were however, substantial differences in the
calculated change in activation energy for channel deactivation
(DEa(ORC)) that are compatible with a model wherein the mutant
subunits have a greater effect on the channel’s open state than the
closed state. The fact that DEa(ORC) is affected by the same
mutations that affect the DG of the open state suggests that the
transition state is similar to the open state, and hence one of the
earliest structural changes to occur during channel deactivation is
a conformational change at the C-terminus of KCNE1 that results
in channel closure. Taken together, these data suggest that the C-
terminus of KCNE1 plays a role in determining the relative free
energy of the open and closed states of the channel, without
affecting the activation energy required to traverse from closed to
open. Furthermore, the results suggest that the wild type KCNE1
C-terminus interaction affects the transition-state energy barrier of
the channel primarily during the open-to-closed transition, thereby
slowing the deactivation rate. Thus, the absence of the C-terminus
appears to affect the relative free energy state in favor of a
stabilized closed state, and lowers the energy barrier for the open-
to-closed transition.
The D76N mutation was one of the first two (along with S74L)
mutations in KCNE1 that were associated with LQTS, providing
evidence that KCNE1 presented a separate LQTS locus, LQT5
[15,40]. It is interesting then that this single amino acid change,
D76N, produces such similar results as the D70 truncation—
significantly faster deactivation rates and ,35 mV right shift in
VDA. The similarities are not due to an abolishment of interaction
between the KCNE1 C-terminus and KCNQ1 by the D76N
mutation. When just the C-terminal portion of KCNE1-D76N is
expressed with full-length KCNQ1, quantifiable binding occurs as
detected by immunoprecipitation and immunoblot. The change
from an acidic R-group to a polar, uncharged R-group, however,
may significantly affect how the residue interacts with its
environment, yielding a C-terminus that cannot properly stabilize
the open state of the KCNQ1/KCNE1 channel or slow its
deactivation kinetics.
Furthermore, our data provide evidence for a role for the
KCNE1 C-terminus in KCNQ1/KCNE1 channel assembly. The
D76N mutation does not reduce the total KCNE1 protein that can
be co-immunoprecipitated with KCNQ1, but the D70 truncation
significantly reduces co-immunoprecipitated KCNE1. The re-
duced likelihood of assembly of the KCNE1-D70 mutant with
KCNQ1 was also demonstrated by the difficulty in achieving pure
IKs current when co-transfecting equimolar KCNQ1 and
KCNE1-D70. Pure saturated KCNQ1/KCNE1-D70 currents
were only reliably achieved by increasing the ratio of KCNQ1-
D70:KCNQ1 cDNA. Thus, C-terminal KCNE1 mutations may
impair the normal formation of KCNQ1/KCNE1 channels that
are successfully trafficked to the plasma membrane. In our
functional studies, where we were able to saturate the KCNQ1
channels with KCNE-D70 subunits, thereby producing current
with IKs-like activation kinetics, the overall current density was
reduced. This may be due to an overall reduction in surface
expression of KCNQ1/KCNE1-D70 channels, because achieving
a workable ratio of KCNQ1 to KCNE1-D70 DNA necessitated
reducing the amount of KCNQ1 DNA used in the transfections.
Because we were able to achieve saturated IKs-like current
regardless of the imposed mutations, our electrophysiological
studies of current accumulation under increasing depolarization
frequency reflect the cumulative effects of changes in deactivation
kinetics, VDA, and current density. In normal cardiac physiology,
action potential durations (APD) shorten to accommodate for
increases in heart rate [29–33]. As cycle-length decreases,
KCNQ1/KCNE1 channels accumulate in the open state,
resulting in an increased potassium conductance and shortened
repolarization phase after subsequent depolarizations. This
accommodation is necessary to maintain the proper electrical
systole:diastole duration ratio. A failure to properly rate-accom-
modate can lead to tachyarrhythmias. In our current accumula-
tion protocol, the normal accumulation of open wild-type
KCNQ1/KCNE1 channels occurs during increased depolariza-
tion frequency without adjusting the duration of the depolariza-
tion. With each depolarization, there is a steady increase in current
density (Figure 6A). If the action potential duration is reduced in
proportion to the frequency, the current accumulation is
completely abolished because there is adequate time for the
channels to deactivate (Figure 6B). When we use the fixed-cycle
length protocol (as in 6A) with either the D76N or D70 mutations,
no current accumulation occurs. We hypothesize that a combi-
nation of increased deactivation rates and the positive shift in
VDA contribute to the defective current accumulation.
Taken together, these findings of channel kinetics and subunit
association we can now firmly delineate the relative contributions
of KCNE1 C-terminus and TMD. The kinetics of activation are
clearly controlled by the TMD, thereby obviating the need for a
complex bipartite model previously advocated [39]. Our data
reveal several possible roles for the KCNE1 C-terminus in
regulating KCNQ1/KCNE1 channel assembly and IKs current.
Thus, there may be multiple mechanisms in which mutations in
the C-terminus cause the exercise-induced phenotypes of LQT1
and LQT5. Mutations may reduce affinity of KCNE1 for
KCNQ1, thereby decreasing the overall surface expression of
functional channels. Other mutations may allow normal assembly,
but affect the thermodynamics or kinetics of gating resulting in
impaired ability to adapt to changes in heart rate. The significance
of the KCNQ1 and KCNE1 C-terminal regions warrants more
detailed studies into how they interact structurally, and how
disease-causing mutations compromise these interactions.
Methods
Plasmids and Cell Culture
Construction and validation of Myc-KCNQ1 and 3X-FLAG-
KCNE1 expression plasmids have been previously described
[13,41]. KCNE1-D76N and KCNE1-D70 mutations were intro-
duced by QuikChangeH Site-Directed mutagenesis (Stratagene).
Primers used for mutagenesis were as follows: KCNE1-D76N (59-
CAC TCG AAC AAC CCA TTC AAC-39); and KCNE1-D70
(59- AGC TAC ATC CGC TCC AAG TAG-39). KCNE1 C-
terminus was cloned from the expression plasmid with the
following primers: 59-CGG AAT TCC ATG CGC TCC AAG
AAG CTG GAG CAC-39 and 59-CGG GAT CCT CAT GGG
GAA GGC TTC GTC TC-39. Subsequently, mutagenesis was
performed to introduce the D76A, D76E, and D76N mutations.
Primers used for mutagenesis were as follows: D76A (59-CAC
TCG AAC GCC CCA TTC AAC-39), D76E (59-CAC TCG
AAC GAA CCA TTC AAC-39), D76N (59-CAC TCG AAC AAC
CCA TTC AAC-39). Sequences of mutated cDNAs were verified
by automated sequencing. Chinese Hamster Ovary (CHO) cells
(American Type Culture Collection) were maintained in Ham’s F-
12 (Mediatech Inc.) supplemented with 10% FBS (Hyclone) and
Penicillin/Streptomycin (Mediatech Inc.) at 37uC and 5% CO2.
Transient transfections were performed using Lipofectamine 2000
(Invitrogen). Molar ratios of 7:7:2 of KCNQ1:KCNE:GFP
KCNE1 C-Terminus Function
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fluorescence. Electrophysiology studies were performed 24–48 hr
after transfection.
Electrophysiology
Transfected CHO cells were grown on sterile glass coverslips
and placed in an acrylic/polystyrene perfusion chamber (Warner
Instruments) mounted in an inverted microscope outfitted with
fluorescence optics and patch pipette micromanipulators. Extra-
cellular solution consisted of NaCl 150 mM, CaCl2 1.8 mM, KCl
4 mM, MgCl2 1 mM, glucose 5 mM, and HEPES buffer 10 mM
(pH 7.4) at room temperature (20–22uC). Intracellular pipette
solution contained KCl 126 mM, K-ATP 4 mM, MgSO4 1 mM,
EGTA 5 mM, CaCl2 0.5 mM, and HEPES buffer 25 mM
(pH 7.2) at room temperature. The whole-cell configuration of
the patch clamp technique was used to measure potassium
currents (Hammill et al., 1981). A MultiClamp 700B patch-clamp
amplifier was used and protocols were controlled via PC using
pCLAMP10 acquisition and analysis software (Axon Instruments).
Patch clamp pipettes were manufactured and tips polished to
obtain a resistance of 2–3 megaOhm in the test solutions. The
pipette offset potential in these solutions was corrected to zero just
prior to seal formation. The junction potential for these solutions
was calculated between 3–4 mV (by pClamp analysis software)
and was not corrected for analyses. Whole cell capacitance
(generally 10–25pF) was compensated electronically through the
amplifier. Whole cell series resistance of 6–12 MV was compen-
sated to 75–90% using amplifier circuitry such that the voltage
errors for currents of 2nA were always less than 6 mV. A standard
holding potential was 280 mV, and figure insets show applied
voltage protocols. Data was filtered using an 8-pole Bessel filter at
1 kHz. Activation kinetics were quantified as a rise time to half
max following a 60 mV depolarizing step from 280 mV holding
potential. Deactivation kinetics were well-fit using a single
standard exponential. For the K
+ conductance accumulation
protocol analysis, outward current during the first 10 ms of the
beginning of each depolarization was averaged.
Co-immunoprecipitation
CHO cells in 60 mm dishes 36–48 hours post-transfection were
placed on ice and lysed with ice-cold NDET buffer (150 mM
NaCl; 1% NP-40; 0.4% Deoxycholic acid; 5 mM EDTA; and
25 mM Tris (pH 7.4)) with complete protease inhibitor cocktail
(Roche Applied Science, EDTA-free) for 15 minutes. Cells were
then scraped into 1.5 mL tubes, incubated on ice for 30 minutes,
and then centrifuged at 16,0006g for 10 minutes at 4uCt o
remove nuclei and cellular debris. The supernatant was pre-
cleared with 20 mL normal goat IgG (Santa Cruz) and 20 mL
Immunopure Ultralink protein G agarose beads (Pierce) for 1 hour
at 4uC. After centrifuging at 5,5006g for 1 minute at 4uC, the
supernatant was incubated with 40 mL goat-anti-KCNQ1 anti-
body (Santa Cruz) and 30 mL protein G beads overnight at 4uC.
The beads were then washed four times with ice-cold NDET, and
eluted by incubation with 46SDS-PAGE sample buffer (4% SDS
(w/v), 40% glycerol, 20% b-mercaptoethanol (v/v), 0.004%
bromphenol blue (w/v), and 125 mM Tris?HCl, pH 6.8) for
30 min at room temperature prior to SDS-PAGE analysis.
SDS-PAGE and Western Blotting
Immunoprecipitated samples were separated on 4–20% gels
(BioRad Criterion
TM), and transferred onto nitrocellulose mem-
brane (BioRad) by semi-dry blotting unit (FisherBiotech). Mem-
branes were blocked with 5% nonfat dry milk in Tris-buffered
saline (TBS) for 30 minutes at room temperature, and then
incubated with anti-myc (1:250, Santa Cruz) and anti-FLAG
(1:5000, Sigma) antibody in 5% non-fat dry milk and 0.05%
Tween 20 in TBS for 2 hours at room temperature or overnight at
4uC. The membranes were then washed four times for 5 minutes
each with 0.05% Tween 20 in TBS and incubated in the
corresponding infrared-fluorescence IRDyeH 800 conjugated
donkey anti-mouse and IRDyeH 700DX conjugated donkey
anti-goat secondary antibodies (Rockland Immunochemicals
Inc.) diluted 1:10,000 for 30 minutes at room temperature in the
dark followed by washing with 0.05% Tween 20 in TBS. The
membranes were then scanned to visualize the signal at 680 nm or
780 nm by the Odyssey detection system (Li-Cor Biosciences).
Linear Free Energy Relationship Calculations
Values for the change in Gibb’s free energy (DG) were calculated
from the isochronal tail currents of each ion channel complex. The
tail currents were fit to a Boltzmann sigmoid curve with equation:
Iv ðÞ ~Io=1ze{kV {Vh ðÞ
Where
Vh~DG

zg
and
k~zg

RT
In this equation, Vh represents the voltage at which K of the
maximal activation occurs and k is the slope factor. The Vh and
slope factor (now termed SF) are related to the DG by the equation:
DG~VhRT x SF
Ea, the activation energy for the transition from the open to closed
stateisrelatedtothefirstorderrateconstantforchanneldeactivation
by the equation:
k~Ae{ Ea=RT ðÞ
Where k is the 1
st-order rate constant of the reaction and Ea is in J/
mol. Given a wild-type and mutant channel, by taking the ratio of
their first order rate constants we can approximate the change in
activation energy (assuming that the proportionality constant A does
not change), as shown below:
k1=k2~e{ Ea1{Ea2 ½  =RT ðÞ
RT ln k1=k2 ðÞ ~Ea1{Ea2
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